September 6, 2019
Announcement no. 18
Updated Financial calendar for 2019 and Financial calendar for 2020
| Date | Description |
| November 21, 2019 | Interim report – for the nine-month period ended September 30th, 2019 |
| February 5, 2020 | Deadline for shareholder proposals - Annual General Meeting |
| February 26, 2020 | Annual Report 2019 |
| March 19, 2020 | Annual General Meeting |
| May 7, 2020 | Interim Report – for the three-month period ended March 31st, 2020 |
| August 19, 2020 | Interim Report – for the six-month period ending June 30th, 2020 |
| November 18, 2020 | Interim report – for the nine-month period ended September 30th, 2020 |
For further information, please contact:
Ole Larsen, CFO
Telephone +45 4529 0000, e-mail investor@bioporto.com
About BioPorto
BioPorto is an in vitro diagnostics company that provides tests and antibodies to clinicians and researchers around the world. We use our antibody and assay expertise to transform novel research tools into clinically actionable biomarkers that can make a difference in patients’ lives. BioPorto is headquartered in Hellerup, Denmark and is listed on the NASDAQ Copenhagen stock exchange [CPH:BIOPOR].
Attachment
